Drugs / liposomal irinotecan hydrochloride
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07077551 | Apr 2025 → Dec 2028 expected | — | Second Affiliated Hospital, School of Medicine, Zhejiang University | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | liposomal irinotecan hydrochloride | “NALIRIFOX (liposomal irinotecan hydrochloride with fluorouracil and oxaliplatin)” NCT07077551 ↗ |